mhurhangee/patent-ind-claim-en huggingface dataset:
A solid state photo-active device (10; 10') comprising: a substrate ; a first electrode disposed on at least one surface of the substrate or disposed within the substrate ; an active layer comprising a photo-active organic salt comprising a counterion selected from the group consisting of halides, aryl borates, carboranes, fluoroantimonates, fluorophosphates, fluoroborates, and combinations thereof; and a second electrode , wherein the active layer is positioned between the first electrode and the second electrode . a substrate ; a first electrode disposed on at least one surface of the substrate or disposed within the substrate ; an active layer comprising a photo-active organic salt comprising a counterion selected from the group consisting of halides, aryl borates, carboranes, fluoroantimonates, fluorophosphates, fluoroborates, and combinations thereof; and a second electrode , wherein the active layer is positioned between the first electrode and the second electrode .
A headrest comprising: a headrest pad disposed inside a headrest cover , and including an elastically deformable cushion portion configuring part of a dynamic damper ; and a mass body configuring part of the dynamic damper and supported by the cushion portion with a center of gravity of the mass body set at a position offset with respect to an elastic center of the cushion portion, the headrest pad includes a first cushion material configuring the cushion portion and a second cushion material with a higher elastic modulus than the first cushion material , in that the center of gravity of the mass body is set at a position offset in at least one of a seat width direction (W) or a seat up-down direction with respect to the elastic center of the cushion portion, and the headrest being characterized in that in that the mass body is formed as a shape with left-right asymmetry. a headrest pad disposed inside a headrest cover , and including an elastically deformable cushion portion configuring part of a dynamic damper ; and a mass body configuring part of the dynamic damper and supported by the cushion portion with a center of gravity of the mass body set at a position offset with respect to an elastic center of the cushion portion, the headrest pad includes a first cushion material configuring the cushion portion and a second cushion material with a higher elastic modulus than the first cushion material , in that the center of gravity of the mass body is set at a position offset in at least one of a seat width direction (W) or a seat up-down direction with respect to the elastic center of the cushion portion, and the headrest being characterized in that in that the mass body is formed as a shape with left-right asymmetry.
A cartridge for a drug delivery device comprising: - a container to receive and/or to store a medicament, wherein the container is sealed by a piston slidably disposed therein, - a writable storage to store assembly-related data, - a microprocessor , and - a communication member to provide device-related data to an automated assembly line adapted to assemble the drug delivery device , wherein at least one of the communication member and the microprocessor is embedded or disposed in the piston , - wherein the storage comprises an assembly configuration of the drug delivery device and wherein the microprocessor is operable to instruct the assembly line regarding actual and/or proceeding steps of assembly according to the data provided by the storage . - a container to receive and/or to store a medicament, wherein the container is sealed by a piston slidably disposed therein, - a writable storage to store assembly-related data, - a microprocessor , and - a communication member to provide device-related data to an automated assembly line adapted to assemble the drug delivery device , wherein at least one of the communication member and the microprocessor is embedded or disposed in the piston , - wherein the storage comprises an assembly configuration of the drug delivery device and wherein the microprocessor is operable to instruct the assembly line regarding actual and/or proceeding steps of assembly according to the data provided by the storage .
A method for recovering at least one valuable containing tungsten, comprising subjecting a raw material mixture comprising at least one valuable containing tungsten to electrolysis using an electrolytic solution containing at least one alcohol amine to dissolve tungsten in the electrolytic solution, electrodeposit a part of the valuable(s) onto a cathode used for the electrolysis and separate at least one valuable other than the valuable(s) electrodeposited onto the cathode as a residue in the electrolytic solution, and then separating the electrolytic solution including tungsten, the valuable(s) electrodeposited onto the cathode, and the residue, and then recovering tungsten dissolved in the electrolytic solution, the at least one valuable in the residue and the valuable(s) electrodeposited onto the cathode.
A split sternum prosthesis comprising a first bone attachment plate and a second bone attachment plate , the first and the second bone attachment plates each have a bone attachment surface and a coupling surface , characterized in that each bone attachment surface is configured to be attached to an incision surface formed along a vertical inline incision after a sternum has been subjected to median sternotomy and thereby divided into a first and second sternum half , and wherein said coupling surface of the first bone attachment plate is configured to be coupled to the coupling surface of the second bone attachment plate .
A method comprising: - subjecting crude methanol extracts of Stylissa carteri sponge to solid phase extraction to produce a library of fractions; - conducting at least one first screening assay of the library of fractions for inhibition of HIV and for cytotoxicity including selecting at least one fraction for further fractionation, - fractionating the at least one fraction further to produce at least one additional fraction; - conducting at least one second screening assay of the at least one additional fraction for inhibition of HIV and for cytotoxicity, including selecting one or more fractions with decreased cytotoxicity for further identification study; - identifying HIV inhibitor molecule candidate(s) based on the inhibition of HIV and decreased cytotoxicity. - subjecting crude methanol extracts of Stylissa carteri sponge to solid phase extraction to produce a library of fractions; - conducting at least one first screening assay of the library of fractions for inhibition of HIV and for cytotoxicity including selecting at least one fraction for further fractionation, - fractionating the at least one fraction further to produce at least one additional fraction; - conducting at least one second screening assay of the at least one additional fraction for inhibition of HIV and for cytotoxicity, including selecting one or more fractions with decreased cytotoxicity for further identification study; - identifying HIV inhibitor molecule candidate(s) based on the inhibition of HIV and decreased cytotoxicity.
Compound of formula wherein M is Mo or W; R 1 is selected from 2,6-dimethylphenyl, 2,6-diisopropylphenyl, 2,6-di-t-butylphenyl, 2,6-dichlorophenyl, adamant-1-yl; R 2 is -C(CH 3 ) 2 C 6 H 5 or -C(CH 3 ) 3 ; R 3 is H; R 5 is selected from pyrrol-1-yl; 2,5-dimethyl-pyrrol-1-yl; triphenylsilyloxy; 2-phenyl-1,1,1,3,3,3-hexafluoro-prop-2-yloxy; 9-phenyl-fluorene-9-yloxy; characterized in that R 4 is selected from 4-bromo-2,6-diphenylphenoxy, 4-fluoro-2,6-diphenylphenoxy, 4-methyl-2,6-diphenylphenoxy, 4-methoxy-2,6-diphenylphenoxy, 2,4,6-triphenylphenoxy, 4-fluoro-2,6-dimesitylphenoxy, 4-bromo-2,6-di-tert.-butylphenoxy, 4-methoxy-2,6-di-tert.-butylphenoxy, 4-methyl-2,6-di-tert.-butylphenoxy, 2,4,6-tri-tert.-butylphenoxy, 4-bromo-2,3,5,6-tetraphenylphenoxy; and 4-bromo-2,6-di(4-bromophenyl)-3,5-diphenylphenoxy. M is Mo or W; R 1 is selected from 2,6-dimethylphenyl, 2,6-diisopropylphenyl, 2,6-di-t-butylphenyl, 2,6-dichlorophenyl, adamant-1-yl; R 2 is -C(CH 3 ) 2 C 6 H 5 or -C(CH 3 ) 3 ; R 3 is H; R 5 is selected from pyrrol-1-yl; 2,5-dimethyl-pyrrol-1-yl; triphenylsilyloxy; 2-phenyl-1,1,1,3,3,3-hexafluoro-prop-2-yloxy; 9-phenyl-fluorene-9-yloxy; characterized in that R 4 is selected from 4-bromo-2,6-diphenylphenoxy, 4-fluoro-2,6-diphenylphenoxy, 4-methyl-2,6-diphenylphenoxy, 4-methoxy-2,6-diphenylphenoxy, 2,4,6-triphenylphenoxy, 4-fluoro-2,6-dimesitylphenoxy, 4-bromo-2,6-di-tert.-butylphenoxy, 4-methoxy-2,6-di-tert.-butylphenoxy, 4-methyl-2,6-di-tert.-butylphenoxy, 2,4,6-tri-tert.-butylphenoxy, 4-bromo-2,3,5,6-tetraphenylphenoxy; and 4-bromo-2,6-di(4-bromophenyl)-3,5-diphenylphenoxy.
A conductive material dispersion liquid comprising a carbon-based conductive material, a dispersant, and a dispersion medium, wherein the dispersant is a copolymer including a first repeating unit represented by Chemical Formula 1 below, a second repeating unit represented by Chemical Formula 2 below, and a third repeating unit represented by Chemical Formula 3 below, and the dispersion medium is a non-aqueous solvent, in Chemical Formula 3, X is hydrogen, a C1 to C30 alkyl group, or a C1 to C30 alkyl ester group, and l is an integer ranging from 1 to 10, and wherein the third repeating unit represented by Chemical Formula 3 is a repeating unit represented by Chemical Formula 3-1 below, in Chemical Formula 3-1, m is an integer ranging from 1 to 20. wherein the dispersant is a copolymer including a first repeating unit represented by Chemical Formula 1 below, a second repeating unit represented by Chemical Formula 2 below, and a third repeating unit represented by Chemical Formula 3 below, and the dispersion medium is a non-aqueous solvent, in Chemical Formula 3, X is hydrogen, a C1 to C30 alkyl group, or a C1 to C30 alkyl ester group, and l is an integer ranging from 1 to 10, and wherein the third repeating unit represented by Chemical Formula 3 is a repeating unit represented by Chemical Formula 3-1 below, in Chemical Formula 3-1, m is an integer ranging from 1 to 20.
Electromechanical parking-lock actuator for actuating a parking lock in a motor vehicle, said actuator including an electric motor and a coupling device , acting by positive closure and/or by force closure, with two coupling parts supported so as to be capable of being rotated or swivelled, of which a first coupling part is actively connected to the motor shaft of the electric motor via a gearing mechanism , whereas the second coupling part is supported so as to be axially relocatable relative to the first coupling part and serves to drive, directly or indirectly, an actuating element acting on a locking pawl of a parking lock , wherein the parking-lock actuator further includes a switching device for optional opening of the coupling device , the second coupling part being actively connected to the electric motor via the first coupling part in the case of a closed coupling device , and being decoupled from the electric motor in the case of an open coupling device , wherein the parking-lock actuator includes an actuator shaft supported so as to be capable of being rotated or swivelled, which is actively connected to the second coupling part of the coupling device and which drives the actuating element acting on the locking pawl of the parking lock , the parking-lock actuator includes a spring element acting on the coupling device , which biases the coupling device into its closed state, characterized in that the switching device of the coupling device includes an electromagnet with a coil surrounding the actuator shaft , wherein in the event of an energising of the electromagnet against the biasing force of the spring element the coupling device is opened, so that the actuating element is capable of being moved independently of the electric motor .
A closure system for a medicament container , the closure system comprising a primary closure adapted for releasably sealing the medicament container; a secondary closure member adapted for releasably sealing the medicament container and comprising ar integrated dosing element; and an adapter arranged to releasably secure the secondary closure member to the primary closure member when the primary closure member is in sealing engagement with the container, the adapter defining a chamber for receiving the dosing element, the chamber being located such as to be inaccessible when the secondary closure member is secured to the primary closure member with the adapter.
A lithium-ion battery module , comprising: - a housing; and - a plurality of lithium-ion battery cells disposed in the housing, wherein each of the plurality of lithium-ion battery cells comprises: - a casing having an electrically conductive material; - a first terminal with a first polarity, the first terminal electrically coupled to the casing ; - a second terminal with a second polarity opposite to the first polarity; and - an overcharge protection assembly , wherein the overcharge protection assembly comprises: - a vent flap comprising a dual door configuration such that the vent flap is configured to open down a crease of the vent flap when a pressure in the casing is equal to or exceeds a threshold value; - a conductive spring electrically coupled to the second terminal ; and - an insulative component disposed between the conductive spring and the casing when the pressure in the casing is below the threshold value; wherein the vent flap is configured to vent a gas from the casing into the housing and to urge the insulative component from between the conductive spring and the casing such that the conductive spring electrically contacts the casing when the pressure in the casing is equal to or exceeds the threshold value by moving from a closed position of the vent flap to an open position of the vent flap . - a housing; and - a plurality of lithium-ion battery cells disposed in the housing, wherein each of the plurality of lithium-ion battery cells comprises: - a casing having an electrically conductive material; - a first terminal with a first polarity, the first terminal electrically coupled to the casing ; - a second terminal with a second polarity opposite to the first polarity; and - an overcharge protection assembly , wherein the overcharge protection assembly comprises: - a vent flap comprising a dual door configuration such that the vent flap is configured to open down a crease of the vent flap when a pressure in the casing is equal to or exceeds a threshold value; - a conductive spring electrically coupled to the second terminal ; and - an insulative component disposed between the conductive spring and the casing when the pressure in the casing is below the threshold value; - a casing having an electrically conductive material; - a first terminal with a first polarity, the first terminal electrically coupled to the casing ; - a second terminal with a second polarity opposite to the first polarity; and - an overcharge protection assembly , - a vent flap comprising a dual door configuration such that the vent flap is configured to open down a crease of the vent flap when a pressure in the casing is equal to or exceeds a threshold value; - a conductive spring electrically coupled to the second terminal ; and - an insulative component disposed between the conductive spring and the casing when the pressure in the casing is below the threshold value;
An isolated and/or artificial pG1-x promoter, which is a functional variant of the carbon source regulatable pG1 promoter of Pichia pastoris identified by SEQ ID 1, which pG1-x promoter consists of or comprises at least a part of SEQ ID 1, which part of SEQ ID 1 has a length of at least 293 bp, which pG1-x promoter comprises the following promoter regions a) at least two copies of a core regulatory promoter region, which core regulatory promoter region comprises the nucleotide sequences SEQ ID 2 and SEQ ID 3, wherein SEQ ID 2 and/or SEQ ID 3 comprises one or more transcription factor binding sites (TFBS); and b) a non-core regulatory promoter region, which is any region within the pG1-x promoter sequence other than the core regulatory region; wherein the pG1-x promoter has a sequence identity to the corresponding region of SEQ ID 1, which is at least 80% to SEQ ID 2 and SEQ ID 3, and at least 50% in any region other than SEQ ID 2 or SEQ ID 3; and further wherein the pG1-x promoter is characterized by an increased promoter strength and/or induction ratio as compared to the pG1 promoter, wherein - the promoter strength is at least 1.1-fold increased in the induced state as compared to the pG1 promoter, and/or - the induction ratio is at least 1.1-fold increased as compared to the pG1 promoter. a) at least two copies of a core regulatory promoter region, which core regulatory promoter region comprises the nucleotide sequences SEQ ID 2 and SEQ ID 3, wherein SEQ ID 2 and/or SEQ ID 3 comprises one or more transcription factor binding sites (TFBS); and b) a non-core regulatory promoter region, which is any region within the pG1-x promoter sequence other than the core regulatory region; - the promoter strength is at least 1.1-fold increased in the induced state as compared to the pG1 promoter, and/or - the induction ratio is at least 1.1-fold increased as compared to the pG1 promoter.
A plastic living hinge comprising: a blend comprising (A) an ethylene-based polymer; and (B) a composite component selected from the group consisting of a block composite, a crystalline block composite, and a combination thereof. (A) an ethylene-based polymer; and (B) a composite component selected from the group consisting of a block composite, a crystalline block composite, and a combination thereof.
A method for purifying a target molecule whereby the target molecule is a protein with a molecular weight of 10000 or more and is separated from leachables and/or extractables by contacting a liquid comprising the target molecule with spherical activated carbon having a mean particle size from 2 to 550 μm obtained by pyrolysis of a spherical organic polymeric material selected from polystyrene, polyamide, polycarbonate, polymethylpentene, polyethylene, polyesters, polyvinyls or polypropylene, said leachables and/or extractables resulting from the contact of disposable equipment employed in the target molecule production and/or purification process with the target molecule or with a liquid comprising the target molecule and said disposable equipment being made of materials including elastomeric or plastic components, whereby the leachables and/or extractables are one or more of the following components: Acetaldehyde, Toluene, 2-Hexanone, Acetone, 2-Butanone, Ethyl Acetate, Bisphenol A, Benzyl alcohol, Trimethyl Silanol, Formaldehyde, Bis (2-ethylhexyl) phthalate, 1-Methylethyl ester acetic acid, 2,4-di-t-butyl Phenol, 2-Octanone, 2-Pentanone, 3,3-dimethyl-2- Butanone, 3-ethoxy-Propane, 3-Hexanone, 3-Methoxy-1-butanol, Butanal, Cyclohexanone, Ethanol, formic acid, Heptaethylene glycol, Hexanal, Methyl isobutyl ketone, Pentanal, t-Butanol, Tetrahydrofuran, Methyl formate and whereby the mean particle size is determined by means of EDANA recommended test method No. WSP 220.2-05 "Particle Size Distribution", where the proportions by mass of the screen fractions are plotted in cumulated form and the mean particle size is determined graphically so that the mean particle size is the value of the mesh size which gives rise to a cumulative 50% by weight.
A diagnostic system for evaluating a physiological condition of bodily tissue, the system comprising: a kinematics module comprising: an ultrasound registration submodule comprising one or more A-mode ultrasound transducers for detecting an interface between a patient's bone and surrounding tissue by detecting ultrasound transducer data of a patient, and an ultrasound dynamic movement submodule comprising one or more inertial measurement units that are operative to feed position information to a computer regarding the 3D position of the one or more ultrasound transducers of the ultrasound registration submodule , wherein the one or more ultrasound transducers are fixedly mounted to the inertial measurement units ; the computer adapted to receive the ultrasound transducer data, the computer including software that is adapted to interpret the ultrasound transducer data and is operable to construct a 3D map having discrete 3D points corresponding to points on the surface of the patient's bone; and wherein the computer is configured to superimpose the 3D map onto a default bone model and thereafter carry out a deformation process of the default bone model resulting in a patient-specific, virtual 3D model of the bone; wherein the computer is adapted to use the position information and the transducer data to create a dynamic patient-specific virtual 3D model of the patient's bone moving in 3D to match the same movement of the patient's bone; and, a visual terminal, associated with the computer, is adapted to display the dynamic patient-specific virtual 3D model. an ultrasound registration submodule comprising one or more A-mode ultrasound transducers for detecting an interface between a patient's bone and surrounding tissue by detecting ultrasound transducer data of a patient, and an ultrasound dynamic movement submodule comprising one or more inertial measurement units that are operative to feed position information to a computer regarding the 3D position of the one or more ultrasound transducers of the ultrasound registration submodule , wherein the one or more ultrasound transducers are fixedly mounted to the inertial measurement units ; the computer adapted to receive the ultrasound transducer data, the computer including software that is adapted to interpret the ultrasound transducer data and is operable to construct a 3D map having discrete 3D points corresponding to points on the surface of the patient's bone; and wherein the computer is configured to superimpose the 3D map onto a default bone model and thereafter carry out a deformation process of the default bone model resulting in a patient-specific, virtual 3D model of the bone; wherein the computer is adapted to use the position information and the transducer data to create a dynamic patient-specific virtual 3D model of the patient's bone moving in 3D to match the same movement of the patient's bone; and, a visual terminal, associated with the computer, is adapted to display the dynamic patient-specific virtual 3D model.
The application of an engineered Corynebacterium glutamicum bacteria having a high production of L-lysine constructed by inactivating the gene NCgl1221 of Corynebacterium glutamicum and having the nucleotide sequence of the NCgl1221 gene encoding frame as set forth in SEQ ID NO.1 in production of L-lysine.